Paclitaxel (Protein-bound Particle) For Injectable Suspension

Send Inquiry

Request To Call Back

Paclitaxel (Protein-bound Particle) For Injectable Suspension

Get a Price/Quote

MOQ : 100 Packs

Paclitaxel (Protein-bound Particle) For Injectable Suspension Specification

Salt Composition
Paclitaxel (Protein-Bound Particle)

Dosage Form
Injectable Suspension

Indication
Breast Cancer, Non-Small Cell Lung Cancer, Pancreatic Cancer

Feature
Solvent-free, Albumin-bound formulation to improve delivery

Ingredients
Paclitaxel (protein-bound), Human albumin

Application

Ph Level
Approximately 7.08.0

Physical Color/Texture
White to off-white lyophilized powder

Fermentation Smell
Odorless

Storage Instructions
AS PER INSTRUCTIONS

Shelf Life
24 Months

USP Compliance
Yes

MSDS Available
Yes

Administration Route
Intravenous Infusion

Solubility
Water Insoluble, Albumin-soluble

Minimum Order Quantity
1 Vial or as per supplier

Compatibility
Compatible with standard IV solvent sets

Brand Name
Paclitaxel (Protein-Bound Particle) For Injectable Suspension

Packaging Type
Single-use Vial

Prescription/Non Prescription
Prescription Only

Concentration
100 mg/vial

Paclitaxel (Protein-bound Particle) For Injectable Suspension Trade Information

Minimum Order Quantity
100 Packs

FOB Port
AHEMDABAD, MUNDRA & MUMBAI

Supply Ability
1000 Packs Per Month

Delivery Time
2 Week

Sample Available
No

Packaging Details
SINGLE USE VIAL

Certifications
AS PER AVAILABILITY

About Paclitaxel (Protein-bound Particle) For Injectable Suspension

PRODUCT NAME:PACLITAXEL (PROTEIN-BOUND PARTICLE) FOR INJECTABLE SUSPENSION

GENERIC NAME: PACLITAXEL (PROTEIN-BOUND PARTICLE) FOR INJECTABLE SUSPENSION

MANUFACTURER: OCEAN

PACKING: FOR SINGLE VIAL

USES: PACLITAXEL Injection is an anti-cancer medication used for the treatment of breast cancer, pancreatic cancer, and non-small cell lung cancer. It is given as an intravenous (IV) injection into your vein, usually over 1 hour and every three weeks.

Advanced Albumin-Bound Chemotherapy

Paclitaxel (Protein-Bound Particle) utilizes human albumin to enhance drug delivery, offering superior targeting of tumor cells with minimized solvent-related toxicity. This innovative formulation is designed for intravenous infusion and is suitable for patients undergoing treatment for multiple cancers including breast, lung, and pancreatic malignancies.

Safe and Convenient Administration

Packaged as a single-use vial containing 100 mg of lyophilized powder, Paclitaxel (Protein-Bound Particle) can be reconstituted and administered using standard IV solvent sets. Its solvent-free composition reduces the risk of hypersensitivity reactions typically associated with conventional chemotherapy agents.

FAQs of PACLITAXEL (PROTEIN-BOUND PARTICLE) FOR INJECTABLE SUSPENSION:

Q: How is Paclitaxel (Protein-Bound Particle) For Injectable Suspension administered?

A: Paclitaxel (Protein-Bound Particle) For Injectable Suspension is administered intravenously as an infusion, using standard IV solvent sets, typically under the supervision of oncology specialists in a clinical setting.

Q: What are the main indications for using this injectable suspension?

A: This medication is indicated for the treatment of breast cancer, non-small cell lung cancer, and pancreatic cancer. It is commonly used as part of chemotherapy protocols in oncology practices.

Q: When should Paclitaxel (Protein-Bound Particle) therapy be initiated?

A: Initiation depends on oncologist assessment and diagnosis. Therapy typically starts when a patient is diagnosed with an appropriate cancer type and oral therapies or conventional medications are not suitable, or when albumin-bound formulations are warranted for safety.

Q: Where can I obtain Paclitaxel (Protein-Bound Particle) For Injectable Suspension?

A: The product is available by prescription through licensed medical facilities, hospitals, and specialty pharmacies. Export and bulk orders can be arranged with the manufacturer in India according to minimum quantity requirements.

Q: What is the process for preparing and storing this injectable suspension?

A: Paclitaxel (Protein-Bound Particle) should be reconstituted as per the instructions provided by the manufacturer and healthcare provider. It must be stored according to specific guidelines and is intended for single use only, with a shelf life of 24 months.

Q: How does the albumin-bound formulation benefit patients?

A: Albumin-binding improves solubility and delivery of Paclitaxel, allowing the medication to be administered without additional solvents, which reduces the risk of adverse reactions and enhances therapeutic efficacy against cancer cells.

Q: What safety features and compliance certifications does this product offer?

A: The product is USP compliant, odorless, solvent-free, and accompanied by a Material Safety Data Sheet (MSDS). Its safety profile is elevated by avoiding solvent-related toxicities and meeting international pharmaceutical standards.

Tell us about your requirement